Lexington, Ky. – The University of Kentucky Markey Cancer Foundation has announced the hiring of Michael Delzotti, CFRE, CSPG, as new president and chief executive officer. Delzotti will begin his new role in early December.
The UK Markey Cancer Foundation serves as the fundraising arm for the UK Markey Cancer Center, the only National Cancer Institute-designated cancer center serving Kentucky and the surrounding Appalachian area. The foundation underwent a nationwide search for their new president and chief executive officer this past summer.
Delzotti comes to Markey from the world-renowned and number one-ranked University of Texas MD Anderson Cancer Center in Houston, where he served as senior director of philanthropic resources. There his role focused on two successive $1.25 billion campaigns. He also directed a $60 million campaign focused on discovering novel drug therapies for Alzheimer’s disease.
Prior to Delzotti’s tenure with MD Anderson Cancer Center, he held major leadership positions with Rice University, UCLA and the Special Olympics of Southern California.
“I am honored to have been chosen by the UK Markey Cancer Foundation Board to join them in their effots,” Delzotti said. “This Center has such a distinguished history of providing world-class care for the citizens of Kentucky and producing cutting-edge research for the entire field of cancer care.
“Our number one goal will be to build the relationships necessary to support Dr. (Mark) Evers’s vision of elevating Markey to NCI Comprehensive Cancer Center status. This designation is so important because it means additional advanced research and comprehensive care for our patients and their families. The Center and the Foundation have one focus – to care for the patient and cure this disease.”
In his new role with the UK Markey Cancer Foundation, Delzotti will also serve as the Foundation’s chief development officer, focusing on major gift development and corporate and foundation grants, as well as overseeing capital campaign initiatives and all other aspects of the Foundation.
With Kentucky’s status as the nation’s leader for overall cancer incidence and mortality, the UK Markey Cancer Center plays an important role in supporting patients around the Commonwealth. Since achieving NCI-designated status in 2013, the Markey Cancer Center has undertaken several new initiatives in the areas of research, treatment and prevention.